Linaclotideyeej yog ib tug laxative. Nws muaj ib qho chaw nrog ib chav kawm ntawm cov tshuaj hu ua guanylate cyclase-C (GC-C) agonists.Linaclotideyog qhov pib pom zoo rau kev kho mob tsis tu ncua idiopathic obstruction (CIC) thiab kev ntxhov siab tsis zoo nrog kev tsis txaus siab (IBS-C) hauv cov neeg laus.
Linaclotide ua haujlwm los ntawm kev tsom mus rau thiab ua haujlwm guanylate cyclase-C receptors hauv plab hnyuv epithelium. Thaum ua tiav, cov receptors no ua rau kev loj hlob ntawm cyclic guanosine monophosphate (cGMP), uas yog li ua rau muaj kev cuam tshuam ntawm lub cev sib txawv hauv plab hnyuv ntau.
Lub hauv paus txheej txheem los ntawm qhov uas linaclotide exerts nws cov nyhuv laxative cuam tshuam nrog kev txhim kho cov hnyuv tso kua dej thiab ua kom lub plab zom mov. Los ntawm kev nce cov tshuaj chloride thiab bicarbonate ions mus rau hauv txoj hnyuv lumen thiab txo kev nqus sodium, linaclotide pab ua kom cov quav mos sib xws thiab txhawb kev zom zaub mov.
Tsis tas li ntawd, linaclotide kuj tseem ua rau txo qis qhov kev xav ntawm kev xav ntau dhau, uas nquag txuas nrog cov xwm txheej zoo li IBS-C. Los ntawm tweaking tactile paj hlwb muaj peev xwm nyob rau hauv lub plab, linaclotide pab nrog txo lub plab mob thiab mob, raws li ntxiv txhim kho feem ntau lub plab muaj peev xwm thiab cov neeg mob solace.
Cov kev tshawb fawb soj ntsuam tau pom qhov ua tau zoo ntawm linaclotide hauv kev txo cov cem quav thiab cov tsos mob plab cuam tshuam nrog CIC thiab IBS-C. Cov neeg mob kho nrog linaclotide tau tshaj tawm txog kev txhim kho cov quav ntau zaus, quav quav, thiab tag nrho lub neej zoo piv rau cov placebo.
Zuag qhia tag nrho, linaclotide yog suav hais tias yog ib qho kev kho mob zoo thiab ua tau zoo rau cov tib neeg uas muaj cem quav thiab mob plab hnyuv nrog cem quav. Ua li ntawd, zoo ib yam nrog rau txhua yam tshuaj, nws yog ib qho tseem ceeb uas yuav tau tham nrog kev kho mob zoo ua ntej pib txoj kev kho mob los txiav txim siab txog cov koob tshuaj uas tsim nyog thiab lav qhov tsim nyog ntawm tus kheej cov keeb kwm kho mob thiab cov tshuaj noj ib txhij.
Linaclotide yog dab tsi thiab nws ua haujlwm li cas?
Linaclotide tsis yog ib txwm muab faib ua laxative, tab sis nws muaj cov nyhuv laxative. Hloov chaw, nws yog nyob rau hauv chav kawm ntawm cov tshuaj hu ua guanylate cyclase-C (GC-C) agonists. Linaclotide feem ntau yog muab rau kev kho mob ntawm tus kab mob idiopathic constipation (CIC) thiab chim siab plob tsis so tswj nrog cem quav (IBS-C) rau cov neeg laus.
Thaum cov tshuaj laxatives ib txwm ua haujlwm los ntawm kev ua kom cov kua dej tso rau hauv txoj hnyuv los yog txhawb kev zom zaub mov los ntawm ntau yam txheej txheem, linaclotide ua haujlwm txawv. Nws cov txheej txheem ntawm kev txiav txim tshwj xeeb yog tsom thiab ua kom cov guanylate cyclase-C receptors hauv plab hnyuv epithelium.
Thaum ua kom muaj zog, cov receptors no txhawb kev tsim cov cyclic guanosine monophosphate (cGMP), uas ua lub luag haujlwm hauv kev tswj hwm ntau yam txheej txheem physiological hauv plab hnyuv. Ib qho ntawm cov teebmeem tseem ceeb ntawm linaclotide yog ua kom cov kua hauv plab tso tawm thiab ua kom lub plab zom mov.
Los ntawm kev txhim kho qhov tso tawm ntawm chloride thiab bicarbonate ions mus rau hauv txoj hnyuv lumen thiab txo qis sodium nqus,linaclotidepab ua kom cov quav mos sib xws thiab txhawb kev zom zaub mov. Tsis tas li ntawd, linaclotide kuj tseem tuaj yeem txo qhov tsis xis nyob hauv plab thiab qhov mob cuam tshuam nrog cov xwm txheej zoo li IBS-C los ntawm kev hloov kho cov paj hlwb hauv plab.
Thaum linaclotide muaj cov nyhuv laxative, nws lub hom phiaj ntawm kev ua haujlwm tau teeb tsa nws sib nrug ntawm cov tshuaj laxatives. Tsis yog tsuas yog ua rau lub plab zom mov lossis ua rau cov quav ntau ntxiv, linaclotide tshwj xeeb yog tsom rau cov kab mob hauv qab ntawm cov kab mob xws li CIC thiab IBS-C los ntawm kev ua kom cov kua dej tso tawm thiab txhawb lub plab zom mov.
Zuag qhia tag nrho, thaum linaclotide yuav raug suav hais tias yog ib qho tshuaj uas muaj cov nyhuv laxative, nws qhov kev faib tawm raws li GC-C agonist qhia txog nws cov txheej txheem tshwj xeeb ntawm kev ua thiab kev kho lub luag haujlwm hauv kev kho mob tshwj xeeb hauv plab hnyuv. Raws li ib txwm muaj, nws yog ib qho tseem ceeb uas yuav tau sab laj nrog tus kws kho mob rau kev taw qhia txog kev siv linaclotide kom tsim nyog raws li tus neeg xav tau kev kho mob thiab kev xav.
Linaclotide vs. Traditional Laxatives: Qhov txawv ntawm qhov tseem ceeb
Thaum ob leeg Linaclotide thiab cov tshuaj laxatives ib txwm siv los txo cov cem quav, lawv txawv ntawm lawv cov txheej txheem ntawm kev ua thiab kev qhia. Cov tshuaj laxatives suav nrog ntau yam tshuaj xws li cov tshuaj stimulant laxatives, osmotic laxatives, thiab cov quav softeners. Cov laxatives no ua haujlwm los ntawm kev ua kom lub plab zom mov, nqus dej rau hauv txoj hnyuv, lossis lubricating cov quav.
Piv txwv li,LinaclotideLub hom phiaj ua haujlwm ntawm GC-C receptors teeb nws sib nrug los ntawm cov tshuaj laxatives. Nws tshwj xeeb hais txog cov txheej txheem ntawm lub cev muaj feem cuam tshuam rau cov kua dej tso tawm thiab lub plab zom mov, ua rau nws nyiam xaiv hauv qee yam mob plab hnyuv xws li IBS-C thiab CIC.
Kev ua tau zoo thiab kev nyab xeeb ntawm Linaclotide hauv Kev Kho Mob
Cov kev tshawb fawb soj ntsuam thiab kev paub hauv ntiaj teb no tau pom tias muaj txiaj ntsig zoo ntawm Linaclotide hauv kev txhim kho lub plab zom mov thiab txo cov tsos mob cuam tshuam nrog IBS-C thiab CIC. Cov neeg mob feem ntau muaj kev mob plab zom mov, txo qhov tsis xis nyob hauv plab, thiab txhim kho lub neej zoo nrog kev kho mob Linaclotide.
Tsis tas li ntawd, Linaclotide tau qhia txog kev nyab xeeb zoo nrog cov kev mob tshwm sim feem ntau. Cov kev mob tshwm sim feem ntau muaj xws li raws plab, mob plab, thiab flatulence, tab sis cov no feem ntau yog me me mus rau nruab nrab thiab ib ntus hauv qhov xwm txheej. Cov neeg mob yuav tsum ua raws li cov tshuaj noj thiab sib tham txog kev txhawj xeeb nrog lawv tus kws kho mob.
Hauv kev xaus, thaumLinaclotideqhia lub hom phiaj ntawm kev tshem tawm cem quav nrog cov tshuaj laxatives, nws cov txheej txheem sib txawv ntawm kev ua thiab cov phiaj xwm cuam tshuam nws txawv ntawm cov tshuaj laxative. Raws li GC-C agonist, Linaclotide muaj kev xaiv kho mob zoo rau cov tib neeg uas muaj IBS-C thiab CIC, hais txog qhov tseem ceeb ntawm kev kho tus kheej hauv kev kho mob plab.
Cov ntaub ntawv:
1. Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide rau kev chim siab plob tsis so tswj nrog cem quav: ib 26-lub lim tiam, randomized, ob-dig muag, placebo-tswj sim los ntsuas kev ua tau zoo thiab kev nyab xeeb. Kuv J Gastroenterol. 2012; 107(11):1702-1712. doi: 10.1038/aug.2012.254
2. Rao S, Lembo AJ, Shiff SJ, et al. Ib 12-lub lim tiam, randomized, tswj kev sim nrog 4-lub lim tiam randomized tshem tawm lub sij hawm los soj ntsuam cov kev ua tau zoo thiab kev nyab xeeb ntawm Linaclotide nyob rau hauv chim siab plob tsis so tswj syndrome nrog cem quav. Kuv J Gastroenterol. 2012; 107(11): 1714-1724. doi: 10.1038/aug.2012.254
3. US Food and Drug Administration. Linzess (Linaclotide) cov lus qhia. Nkag mus rau lub Peb Hlis 2024.
4. Johnston JM, Kurtz CB, Macdougall JE, et al. Linaclotide txhim kho qhov mob plab thiab plab hnyuv hauv theem IIb txoj kev tshawb fawb ntawm cov neeg mob uas mob plab hnyuv plab nrog cem quav. Gastroenterology. 2010; 139(6):{4}}. doi: 10.1053/j.gastro.2010.07.048
5. Lembo AJ, Schneier HA, Shiff SJ, et al. Ob qhov kev sim randomized ntawm linaclotide rau cem quav ntev. N Engl J Med. 2011; 365(6):{4}}. doi: 10.1056/NEJMoa1010863